Prosecution Insights
Last updated: October 25, 2026

Amin Wasserman Gurnani LLP

Technology area: Biotechnology & Pharmaceuticals

31 pending office actions • 27 clients • 30 examiners • 28 art units • 0 of 31 (0%) have an AI response strategy ready

Analysis

AMIN WASSERMAN GURNANI LLP has 32 pending office actions in Biotechnology & Pharmaceuticals and 769 career applications. Its resolved allowance rate is 75.0%, and the average number of office actions per allowance is 2.85. The application base provides context for the current docket and the reported outcome measures.

The allowance rate is the central outcome signal in this profile, while the office-action average describes the amount of examination activity typically associated with an allowance. For practitioners, the figures support review of claim strategy and response practice in biotechnology and pharmaceuticals. The pending matters should also be assessed for recurring rejection grounds or opportunities to streamline prosecution.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=769 apps, methodology: how we score firms)

75.0%
Allowance Rate
n=769
+0.53σ
Allowance Rate (norm)
n=769
2.8
OAs to Allowance
n=300
-0.44σ
OAs to Allow (norm)
n=300
852 days
Time to Allowance
n=300
+10.0pp
Interview Lift
n=769
18.5%
RCE Rate
n=769
1.0%
Appeal Rate
n=769

Rejection Performance (% of received rejections ultimately overcome)

50.9%
§101 Overcome
n=57
59.5%
§102 Overcome
n=148
57.9%
§103 Overcome
n=252
60.4%
§112 Overcome
n=235

Specialization & Scale

A61K, A61P, A23L
Top CPC Subclasses
31%
Top-3 CPC Share
n=769
0
Practitioners
n=769
—
Apps / Practitioner
n=769 (min 20)

Portfolio Summary

31
Total Pending OAs
22
Non-Final OAs
9
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
4
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

21
Hard (68%)
4
Medium (13%)
6
Easy (19%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other5 (16%)
§103 only3 (10%)
§102 only1 (3%)
§112 only6 (19%)
Multi-statute (no §101)16 (52%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

17
Life Sciences
55% of docket
0
Information Tech
0% of docket
1
Communications
3% of docket
4
Semiconductors
13% of docket
8
Mechanical / Eng
26% of docket
1
Business / Other
3% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

310 h
Manual time on pending OAs
62 h
Time saved (low, 20%)
108 h
Time saved (mid, 35%)
2.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TOPOLSKI, MAGDALENA 2 56.5% +41.0%
HIBBERT, MARY C 1 66.7% +26.4%
TSAI, TSUNG YIN 1 81.6% +11.6%
LO, ANDREW S 1 72.2% +27.7%
BELLINGER, JASON R 1 70.0% +18.7%
ARIANI, KADE 1 75.0% +32.0%
ROBINSON, HOPE A 1 67.7% +43.0%
TEJANI, ANKIT D 1 81.0% +16.3%
DUONG, HENRY ABRAHAM 1 79.0% +7.4%
HERRING, LISA L 1 72.9% +17.2%

Hard Cases (21)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18681619 AN OPTICAL SYSTEM FOR FREQUENCY CONVERSION OF A SINGLE PHOTON PETKOVSEK, DANIEL 30d overdue
18689615 SYSTEM FOR CALIBRATING A SENSOR JAGAN, MIRELLYS 8d
18708061 MEAT-ALTERNATIVE PRODUCT INCLUDING OILSEED PRESS CAKES MERRIAM, ANDREW E 13d
18487670 A DISPENSING DEVICE WITH AN ELECTROMECHANICAL FEEDBACK SYSTEM AND METHODS OF USE SPARKS, RUSSELL E 27d
19532051 POWDER FILLING TECHNOLOGY FOR AEROSOL CANISTERS HIBBERT, MARY C —
19109270 POINT CLOUD REGISTRATION METHOD, APPARATUS AND ELECTRONIC EQUIPMENT BASED ON PLANE FITTING TSAI, TSUNG YIN —
18997247 A WHEEL FOR A PUSHCHAIR AND A PUSHCHAIR HAVING A WHEEL BELLINGER, JASON R —
18995589 PROBIOTIC BLEND SUPPLEMENT WITH MICRONUTRIENTS FOR INFANT AND CHILDREN'S HEALTH ARIANI, KADE —

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19532051 POWDER FILLING TECHNOLOGY FOR AEROSOL CANISTERS HIBBERT, MARY C —
19109270 POINT CLOUD REGISTRATION METHOD, APPARATUS AND ELECTRONIC EQUIPMENT BASED ON PLANE FITTING TSAI, TSUNG YIN —
19049611 ACTUATOR GEARED FEEDBACK SYSTEM FOR A RESISTANCE TRAINING MACHINE AND METHODS OF USE LO, ANDREW S —
18997247 A WHEEL FOR A PUSHCHAIR AND A PUSHCHAIR HAVING A WHEEL BELLINGER, JASON R —
18995589 PROBIOTIC BLEND SUPPLEMENT WITH MICRONUTRIENTS FOR INFANT AND CHILDREN'S HEALTH ARIANI, KADE —
18881959 PEROXIDASE BASED BIOCONTROL AGENTS ROBINSON, HOPE A —
18944999 METHOD AND WEARABLE TRACKER SYSTEM FOR HEALTH CONDITIONS AND DIAGNOSIS TEJANI, ANKIT D —
18860107 CHAIN TENSIONERS FOR MOORING OF OFFSHORE FLOATING STRUCTURES TOPOLSKI, MAGDALENA —

Client Portfolio (27 clients)

Top Art Units

Art UnitApps
36422
16572
37311
26561
37841
36151
16511
16521
37961
28721

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19532051 POWDER FILLING TECHNOLOGY FOR AEROSOL CANISTERS Tri-Pac, Inc. HIBBERT, MARY C 3731 §103§112 Non-Final OA — Pending Feb 06, 2026
19109270 POINT CLOUD REGISTRATION METHOD, APPARATUS AND ELECTRONIC EQUIPMENT BASED ON PLANE FITTING Fair Innovation (Suzhou) Robot System Co., Ltd. TSAI, TSUNG YIN 2656 §101§102§103 Non-Final OA — Pending Mar 06, 2025
19049611 ACTUATOR GEARED FEEDBACK SYSTEM FOR A RESISTANCE TRAINING MACHINE AND METHODS OF USE Speede Fitness, LLC LO, ANDREW S 3784 §112 Non-Final OA — Pending Feb 10, 2025
18997247 A WHEEL FOR A PUSHCHAIR AND A PUSHCHAIR HAVING A WHEEL Jijibaba Limited BELLINGER, JASON R 3615 §102§103§112 Non-Final OA — Pending Jan 21, 2025
18995589 PROBIOTIC BLEND SUPPLEMENT WITH MICRONUTRIENTS FOR INFANT AND CHILDREN'S HEALTH Resbiotic Nutrition, Inc. ARIANI, KADE 1651 §102§103§112 Non-Final OA — Pending Jan 16, 2025
18881959 PEROXIDASE BASED BIOCONTROL AGENTS Acies Bio D.O.O. ROBINSON, HOPE A 1652 §102§112 Non-Final OA — Pending Jan 07, 2025
18944999 METHOD AND WEARABLE TRACKER SYSTEM FOR HEALTH CONDITIONS AND DIAGNOSIS Rosalind Franklin University Of Medicine And Science TEJANI, ANKIT D 3796 §102§112Other Non-Final OA — Pending Nov 12, 2024
18860107 CHAIN TENSIONERS FOR MOORING OF OFFSHORE FLOATING STRUCTURES I.P. Huse AS TOPOLSKI, MAGDALENA 3642 §103§112 Non-Final OA — Pending Oct 25, 2024
18859654 HOLOGRAPHIC SYSTEM WITH IMPROVED PROJECTION QUALITY Syddansk Universitet DUONG, HENRY ABRAHAM 2872 §101§102§103 Non-Final OA — Pending Oct 24, 2024
18849925 MASS-PRODUCED GLASS CONTAINER WITH VISIBLE LIGHT SHIELDING AND FABRICATION METHOD THEREOF USING RECOVERED POST-CONSUMER GLASS BEWEX B.V. HERRING, LISA L 1741 §112 Non-Final OA — Pending Sep 23, 2024
18821273 THE ANTI-INFLAMMATORY ROLE OF CANNABIDIOL, RETINYL PALMITATE, BETA-CARYOPHYLLENE AND TRIBUTYRIN WHEN ADMINISTERED IN CONJUNCTION Flg Sciences, LLC THOMAE, EVAN GODFREY 1623 §103Other Non-Final OA — Pending Aug 30, 2024
18839259 LONG OFFSET LOW FREQUENCY SEISMIC SURVEYS USING OPTICAL FIBERS Ntnu - Norges Teknisk - Naturvitenskapelige Universitet N'DURE, AMIE MERCEDES 3645 §103 Final Rejection — Pending Aug 16, 2024
18802534 COLLAGEN SERUM FORMULATIONS AND METHODS OF USE THEREOF Wellbeam Consumer Health Intermediate, LLC TRUONG, QUANGLONG N 1615 §101§103§112DP Non-Final OA — Pending Aug 13, 2024
18837366 ADHESIVE FILM Hueck Folien Gesellschaft m.b.H. LE, HOA T 1788 §112 Final Rejection 8d Pending Aug 09, 2024
18729290 GENETICALLY MODIFIED BACTERIA RESISTANT TO MASS CELL LYSIS Acies Bio D.O.O. MISHRA, DEEPA §102§103§112 Non-Final OA — Pending Jul 16, 2024
18728748 CEMENT REPLACEMENT MIXTURE Restone AS GREEN, ANTHONY J 1731 §112 Non-Final OA — Pending Jul 12, 2024
18763849 SYNERGIES OF 1- BETA-CARYOPHYLLENE, CANNABIDIOL AND TRIBUTYRIN; 2- RETINYL PALMITATE, BETA-CARYOPHYLLENE AND CANNABIDIOL; 3- RETINYL PALMITATE AND BETA-CARYOPHYLLENE IN CONTROLING INFLAMMATION, METABOLIC HEALTH, INSULIN SENSITIVITY/ GLYCEMIC - GLUCOSE UPTAKE & MANAGEMENT, AND FATTY LIVER/ NAFLD Flg Sciences, LLC SHAMEEM, GOLAM M 1621 §112 Non-Final OA — Pending Jul 03, 2024
18718566 A CHAIN LOAD MONITORING UNIT, AND AN INSTALLATION TOOL AND A METHOD FOR INSTALLING A CHAIN LOAD MONITORING UNIT Kongsberg Maritime AS NGUYEN, QUANG X.L. 2853 §102§103 Non-Final OA — Pending Jun 11, 2024
18712767 BACILLUS MEGATERIUM STRAIN, COMPOSITIONS THEREOF, AND METHODS OF USE Deerland Probiotics & Enzymes, Inc. AFREMOVA, VERA 1653 §101§102§103§112 Non-Final OA — Pending May 23, 2024
18712764 BACILLUS COAGULANS STRAIN, COMPOSITIONS THEREOF, AND METHODS OF USE Deerland Probiotics & Enzymes, Inc. EDWARDS, JESSICA FAYE 1657 §102§103§112 Final Rejection — Pending May 23, 2024
18712144 A BREASTFEEDING ANALYSIS DEVICE AND SYSTEM Ent Research Clinic Horsens YOON, CHANEL J 3791 §112 Non-Final OA — Pending May 21, 2024
18708061 MEAT-ALTERNATIVE PRODUCT INCLUDING OILSEED PRESS CAKES More Alternative Foods Ltd. MERRIAM, ANDREW E 1791 §103§112 Final Rejection 13d Pending May 07, 2024
18691136 A SYSTEM AND METHOD FOR MOORING OF AND SUPPLY ELECTRICAL POWER TO A VESSEL Kongsberg Maritime AS TOPOLSKI, MAGDALENA 3642 §102 Final Rejection — Pending Mar 12, 2024
18689615 SYSTEM FOR CALIBRATING A SENSOR Ametek Denmark A/S JAGAN, MIRELLYS 2855 §103§112 Final Rejection 8d Pending Mar 06, 2024
18682649 COMPOUNDS FOR TREATMENT OF VIRAL INFECTIONS BY NEUROTROPIC VIRUS Michael Hans Willi Lappe REDWOOD, CHRISTOPHER EVAN 1629 §103 Final Rejection — Pending Feb 09, 2024
18681619 AN OPTICAL SYSTEM FOR FREQUENCY CONVERSION OF A SINGLE PHOTON Aarhus Universitet PETKOVSEK, DANIEL 2874 §103§112 Non-Final OA 30d overdue Pending Feb 06, 2024
18487670 A DISPENSING DEVICE WITH AN ELECTROMECHANICAL FEEDBACK SYSTEM AND METHODS OF USE Airo Brands Inc. SPARKS, RUSSELL E 1747 §103§112 Non-Final OA 27d Pending Oct 16, 2023
18466680 NOVEL DIAGNOSTIC AND METHOD OF SCREENING THERAPEUTICS FOR FIBROTIC CONDITIONS Blr-Bio, LLC WARD, AARON DUREL 1636 §101§102§103§112 Non-Final OA — Pending Sep 13, 2023
18184456 METHODS OF PRODUCING CRYSTALLINE BETA NICOTINAMIDE RIBOSIDE TRIACETATE CHLORIDE Chromadex Inc. LAU, JONATHAN S 1693 §102§103Other Final Rejection — Pending Mar 15, 2023
17966267 METHOD FOR LIBERATING INTRACELLULAR MATERIAL FROM PLANT CELLS Deerland Enzymes, Inc. CHEN, CATHERYNE 1655 §103§112 Non-Final OA — Pending Oct 14, 2022
17872540 METHOD FOR ANALYZING ILEOSTOMY SUBJECTS USING A PROBIOTIC CONTAINING BACILLUS SUBTILIS Adm Cork H&W Limited DURYEE, ALEXANDER MARSH 1657 §103§112 Final Rejection — Pending Jul 25, 2022

Managing Amin Wasserman Gurnani LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Amin Wasserman Gurnani LLP's patent allowance rate?

75.0% of resolved applications prosecuted by Amin Wasserman Gurnani LLP were allowed, across 769 applications in USPTO records.

How many office actions does Amin Wasserman Gurnani LLP average before allowance?

2.85 office actions per allowed application on average.

How many pending office actions does Amin Wasserman Gurnani LLP have?

31 pending office actions as of October 2026, for 27 clients, before 30 examiners in 28 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month